Featured Product Partner the leva Pelvic Health System

JOIN OUR NEWSLETTER

Get the latest news and information
from NAFC directly to you inbox

SPOTLIGHT ON: the leva®pelvic health system, By Renovia

leva

leva pelvic health system

Renovia Inc. (“Renovia”) is a women-led company dedicated to improving the lives of women with pelvic floor disorders. Renovia’s flagship product, the leva® Pelvic Health System, offers a novel, effective, first-line treatment for urinary incontinence (UI), an underreported condition affecting 20 million women in the U.S. alone.

UI negatively impacts women’s quality of life and can contribute to other potentially severe medical conditions. Despite its prevalence and adverse effects on women’s health, UI is often underreported by women and thus not addressed by many clinicians. Fortunately, groups such as ACOG (American College of Obstetricians and Gynecologists) and WPSI (Women’s Preventive Services Initiative) are increasingly recommending screening for pelvic floor disorders including UI. Early intervention has been shown to resolve or reduce symptoms, improve immediate and long-term condition-specific quality of life, and limit the need for more invasive and costly treatments.

The leva Pelvic Health System offers a novel, non-invasive, medication-free way for women to train and strengthen their pelvic floor muscles—at home in just five minutes a day—to treat urinary incontinence. Combining a small FDA-cleared vaginal wand connected to a smartphone app, leva offers precise visualization of pelvic movement in real-time, enables progress tracking and allows active physician involvement, all of which support a women’s success.

leva is available by prescription, allowing physicians the opportunity to treat UI on a broad scale and with continued involvement in patient success. Published data from globally recognized medical centers support leva’s efficacy. The Digital Therapeutics Alliance, a global, non-profit organization that advances quality digital therapeutics in healthcare, includes leva in its Product Library, indicating that it meets DTA’s rigorous definition of an evidence-based digital therapeutic and satisfies its ten rigorous Core Principles. Renovia is the first company focused solely on women’s health to have a product included in the DTA Product Library.

For more information about Renovia or the leva Pelvic Health System please visit www.renoviainc.com or follow the company on Twitter, Facebook, LinkedIn and Instagram.

Important Indication and Other Information for the leva Pelvic Health System 

The leva Pelvic Health System is intended for strengthening of pelvic floor muscles, and rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed, and mild to moderate urgency urinary incontinence (including overactive bladder) in women. Treatment with the leva System is by prescription and is not for everyone. Please talk to your prescriber to see if leva is right for you. Your prescriber should discuss all potential benefits and risks with you. Do not use leva while pregnant, or if you think you may be pregnant, unless authorized by your doctor. For a complete summary of the risks and instructions for the leva System, see its Instructions for Use available at www.renoviainc.com.

Renovia Inc. and leva® are trademarks or registered trademarks of Renovia Inc. in the United States and other countries. All Rights Reserved.